O	0	6	Impact
O	7	9	of
B-intervention	10	15	Awake
I-intervention	16	22	Breast
I-intervention	23	29	Cancer
I-intervention	30	37	Surgery
O	38	40	on
B-condition	41	54	Postoperative
I-condition	55	65	Lymphocyte
I-condition	66	75	Responses
O	75	76	.

O	77	85	Surgical
O	86	92	stress
O	93	96	and
O	97	107	anesthesia
O	108	114	affect
O	115	118	the
O	119	126	patient
O	126	127	'
O	127	128	s
O	129	135	immune
O	136	142	system
O	142	143	.

O	144	152	Analysis
O	153	155	of
O	156	159	the
O	160	170	lymphocyte
O	171	179	response
O	180	185	after
O	186	192	breast
O	192	193	-
O	193	203	conserving
O	204	211	surgery
O	212	215	was
O	216	225	conducted
O	226	228	to
O	229	240	investigate
O	241	244	the
O	245	256	differences
O	257	264	between
O	265	272	effects
O	273	278	after
O	279	286	general
O	287	290	and
O	291	296	local
O	297	307	anesthesia
O	307	308	.

B-total-participants	309	314	Fifty
I-total-participants	314	315	-
I-total-participants	315	318	six
B-eligibility	319	327	patients
I-eligibility	328	332	with
I-eligibility	333	339	breast
I-eligibility	340	346	cancer
O	347	351	were
O	352	360	enrolled
O	361	364	for
O	365	368	BCS
O	369	376	through
O	377	382	local
O	383	385	or
O	386	393	general
O	394	404	anesthesia
O	404	405	.

O	406	411	Total
O	412	422	leukocytes
O	422	423	,
O	424	429	total
O	430	441	lymphocytes
O	441	442	,
O	443	453	lymphocyte
O	453	454	-
O	454	461	subsets
O	462	471	including
O	472	475	CD3
O	475	476	+
O	476	477	,
O	478	482	CD19
O	482	483	+
O	483	484	,
O	485	488	CD4
O	488	489	+
O	489	490	,
O	491	494	CD8
O	494	495	+
O	495	496	,
O	497	501	CD16
O	501	502	+
O	502	506	CD56
O	506	507	+
O	508	511	and
O	512	515	CD4
O	515	516	+
O	516	517	/
O	517	520	CD8
O	520	521	+
O	522	527	ratio
O	528	531	was
O	532	540	examined
O	541	543	at
O	544	552	baseline
O	553	556	and
O	557	559	on
O	560	573	postoperative
O	574	578	days
O	579	580	1
O	580	581	,
O	582	583	2
O	584	587	and
O	588	589	3
O	589	590	.

O	591	599	Baseline
O	600	604	data
O	605	611	showed
O	612	614	no
O	615	626	statistical
O	627	637	difference
O	638	645	between
O	646	649	the
O	650	653	two
O	654	660	groups
O	660	661	.

O	662	668	Within
O	668	669	-
O	669	674	group
O	675	680	ANOVA
O	681	685	test
O	686	692	showed
O	693	704	significant
O	705	716	differences
O	717	720	for
B-outcome	721	726	total
I-outcome	727	736	leukocyte
I-outcome	737	742	count
O	743	744	(
O	744	745	p
O	745	746	<
O	746	747	0
O	747	748	.
O	748	751	001
O	751	752	)
O	752	753	,
B-outcome	754	759	total
I-outcome	760	770	lymphocyte
I-outcome	771	776	count
O	777	778	(
O	778	779	p
O	779	780	=
O	780	781	0
O	781	782	.
O	782	785	009
O	785	786	)
O	787	790	and
B-outcome	791	801	proportion
I-outcome	802	804	of
I-outcome	805	812	natural
I-outcome	812	813	-
I-outcome	813	819	killer
I-outcome	820	825	cells
O	826	827	(
O	827	828	p
O	828	829	=
O	829	830	0
O	830	831	.
O	831	833	01
O	833	834	)
O	835	837	in
O	838	841	the
O	842	849	control
O	850	855	group
O	855	856	.

O	857	864	Between
O	864	865	-
O	865	870	group
O	871	879	analysis
O	880	886	showed
O	887	892	lower
B-outcome	893	899	median
I-outcome	900	906	values
I-outcome	907	909	of
I-outcome	910	915	total
I-outcome	916	927	lymphocytes
O	928	930	in
O	931	934	the
O	935	940	awake
O	941	948	surgery
O	949	954	group
B-outcome	955	957	on
I-outcome	958	971	postoperative
I-outcome	972	976	days
I-outcome	977	978	1
I-outcome	978	979	,
I-outcome	980	981	2
I-outcome	982	985	and
I-outcome	986	987	3
O	988	989	(
O	989	990	p
O	990	991	=
O	991	992	0
O	992	993	.
O	993	996	001
O	996	997	,
O	998	999	p
O	999	1000	=
O	1000	1001	0
O	1001	1002	.
O	1002	1004	02
O	1005	1008	and
O	1009	1010	p
O	1010	1011	=
O	1011	1012	0
O	1012	1013	.
O	1013	1015	01
O	1015	1016	,
O	1017	1029	respectively
O	1029	1030	)
O	1031	1035	when
O	1036	1044	compared
O	1045	1047	to
O	1048	1051	the
O	1052	1059	control
O	1060	1065	group
O	1065	1066	.

O	1067	1075	Patients
O	1076	1079	who
O	1080	1089	underwent
O	1090	1097	surgery
O	1098	1103	under
O	1104	1111	general
O	1112	1122	anesthesia
O	1123	1126	had
O	1127	1133	higher
B-outcome	1134	1139	total
I-outcome	1140	1150	lymphocyte
I-outcome	1151	1157	counts
I-outcome	1158	1160	on
I-outcome	1161	1174	postoperative
I-outcome	1175	1178	day
O	1179	1180	2
O	1181	1182	(
O	1182	1183	p
O	1183	1184	=
O	1184	1185	0
O	1185	1186	.
O	1186	1188	04
O	1188	1189	)
O	1189	1190	.

O	1191	1193	In
O	1194	1198	this
O	1199	1209	randomized
O	1210	1215	study
O	1215	1216	,
O	1217	1223	breast
O	1223	1224	-
O	1224	1234	conserving
O	1235	1242	surgery
O	1243	1247	plus
O	1248	1253	local
O	1254	1264	anesthesia
O	1265	1268	had
O	1269	1270	a
O	1271	1276	lower
O	1277	1283	impact
O	1284	1286	on
O	1287	1300	postoperative
O	1301	1311	lymphocyte
O	1312	1320	response
O	1321	1325	when
O	1326	1334	compared
O	1335	1337	to
O	1338	1341	the
O	1342	1346	same
O	1347	1356	procedure
O	1357	1366	performed
O	1367	1372	under
O	1373	1380	general
O	1381	1391	anesthesia
O	1391	1392	.
